U.S. FDA Pilot Program Will Speed U.S. Entry Of Drugs With Secure Supply Chains
This article was originally published in PharmAsia News
Executive Summary
FDA is developing an implementation plan for pilot testing a program to speed entry into the U.S. of drugs that flow through a strong supply chain